Mira Jung
CIK: 0001945307
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Officer
Discretionary Trading P&L
Holdings
About Jung Mira
Jung Mira (SEC CIK 0001945307) files insider reports with the SEC as Chief Scientific Officer of Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Signal8 holds 1 ownership filing by Jung Mira, a Form 4, filed on Oct 9, 2024. Those filings report 1 transaction, the latest on May 1, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Jung Mira's filings is in ROCKVILLE, MD.
Recent filings by Jung Mira
- May 1, 2024: Grant or award of SHPH shares (Form 4, code A).
Other insiders filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- HRT FINANCIAL LP, 10% Owner
- Trasolini Ryan, Co-Chief Executive Officer
- Liang Yuying, Chief Financial Officer
- Liriano Angel, Director
- Pathigoda Arachchige Sachin Eranga, Director
- Chambers Adam V, Director